Ollin Biosciences

About Ollin Biosciences

Ollin Biosciences is a clinical-stage biotechnology company focused on developing differentiated therapeutics for serious, common ophthalmic diseases. The company identifies, acquires, and develops therapeutic programs with a commitment to scientific rigor and transparency. Ollin targets biologies designed to make meaningful improvements to patient care and treatment outcomes in ophthalmology, utilizing the latest technologies in ophthalmic imaging and data sciences to inform drug development activities. The company prioritizes building a supportive, motivating work environment that empowers team members to make informed decisions and fosters transparent communication about challenges and impact.